Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Revance Therapeutics Inc (NASDAQ:RVNC)

During the Trading Day
16.77 -0.06 / -0.36%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
16.77 0.00 / 0.00%
 
Volume: 200.00
No recent news for Revance Therapeutics Inc.

Today’s Trading

Previous close16.83
Today’s open16.56
Day’s range16.01 - 17.44
Volume304,121
Average volume (3 months)452,746
Market cap$472.3M
Dividend yield--
Data as of 4:00pm ET, 02/11/2016

Growth & Valuation

Earnings growth (last year)-408.57%
Earnings growth (this year)+5.97%
Earnings growth (next 5 years)--
Revenue growth (last year)-37.93%
P/E ratioNM
Price/Sales857.68
Price/Book2.27

Competitors

 Today’s
change
Today’s
% change
CTMXCytomX Therapeutics ...-1.05-8.06%
PDLIPDL BioPharma Inc-0.04-1.37%
SGNTSagent Pharmaceutica...-0.03-0.21%
ENTAEnanta Pharmaceutica...+1.25+5.14%
Data as of 4:00pm ET, 02/11/2016

Financials

Next reporting dateMarch 23, 2016
EPS forecast (this quarter)-$0.86
Annual revenue (last year)$383.0K
Annual profit (last year)-$62.9M
Net profit margin-16,427.42%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
L. Daniel Browne
Chief Operating Officer
Abhay Joshi
Corporate headquarters
Newark, California

Forecasts

Partner Offers